Crossmark

Comment on: “Hematological Toxicity of PARP Inhibitors in Metastatic Prostate Cancer Patients with Mutations of BRCA or HRR Genes: A Systematic Review and Safety Meta‑analysis”

Crossref DOI link: https://doi.org/10.1007/s11523-024-01082-9

Published Online: 2024-07-19

Published Print: 2024-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ma, Jun

Han, Wei
Funding

Funding for this research was provided by:

Kunshan Major Project of Social Research and Development (KS18035)
License Information

Text and Data Mining valid from 2024-07-19

Version of Record valid from 2024-07-19
More Information

Article History

Accepted: 27 June 2024

First Online: 19 July 2024

Declarations

:

: Kunshan Major Project of Social Research and Development (No. KS18035).

: Jun Ma and Wei Han declare that they have no conflicts of interest that might be relevant to the contents of this letter.

: Not applicable.

Document is current

Any future updates will be listed below